Principal Investigators
A/Pr Julie Atkin
Institution
Macquarie University
Contact information of lead PI
Country
Australia
Title of project or programme
Cellular transport dysfunction and motor neuron disease
Source of funding information
National Health and Medical Research Council
Total sum awarded (Euro)
291,217
Start date of award
01/01/2012
Total duration of award in years
5
Keywords
Research Abstract
Amyotrophic lateral sclerosis (ALS) patients currently face a bleak future. In the common global form of disease, the average length of survival after diagnosis is 31 months. Current therapies have at best a modest effect on the course of the disease with little or no benefit in terms of overall patient survival. This study will address the basic underlying biochemical mechanisms of disease in both sporadic and genetic forms of ALS. This studies will lead to opportunities to develop new therapies in the future.
Further information available at:
Types: Investments < €500k
Member States: Australia
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A